ArticleFrontiers in oncology2022
Clinical Benefit With PARP Inhibitor for Pathogenic Germline
Bing Qian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it
ArticleFrontiers in oncology2022
Bing Qian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.